ARROWHEAD PHARMACEUTICALS, INC. Unrealized Gain (Loss) on Derivatives
ARROWHEAD PHARMACEUTICALS, INC. (ARWR) reported Unrealized Gain (Loss) on Derivatives of $432.14 thousand for the 12-month period ending 2018-09-30, per its 10-K filed 2020-11-23.
Discontinued › Cash Flow › Operating Activities
us-gaap:UnrealizedGainLossOnDerivatives · last filed 2020-11-23
- ARROWHEAD PHARMACEUTICALS, INC. unrealized gain (loss) on derivatives for the quarter ending 2018-09-30 was $0.00.
- ARROWHEAD PHARMACEUTICALS, INC. unrealized gain (loss) on derivatives for the quarter ending 2018-06-30 was $0.00, a 100.00% decline year-over-year.
- ARROWHEAD PHARMACEUTICALS, INC. unrealized gain (loss) on derivatives for the quarter ending 2018-03-31 was -$18.60K.
- ARROWHEAD PHARMACEUTICALS, INC. unrealized gain (loss) on derivatives for the quarter ending 2017-12-31 was $450.74K, a 69.62% decline year-over-year.
- ARROWHEAD PHARMACEUTICALS, INC. unrealized gain (loss) on derivatives for fiscal 2018 was $432.14K, a 51.46% decline from fiscal 2017.
- ARROWHEAD PHARMACEUTICALS, INC. unrealized gain (loss) on derivatives for fiscal 2017 was $890.36K.
- ARROWHEAD PHARMACEUTICALS, INC. unrealized gain (loss) on derivatives for fiscal 2016 was -$301.02K, a 110.49% decline from fiscal 2015.
- ARROWHEAD PHARMACEUTICALS, INC. unrealized gain (loss) on derivatives for fiscal 2015 was $2.87M.
| Period end | Unrealized Gain (Loss) on Derivatives 3 month | Unrealized Gain (Loss) on Derivatives 6 month | Unrealized Gain (Loss) on Derivatives 9 month | Unrealized Gain (Loss) on Derivatives 12 month | Unrealized Gain (Loss) on Derivatives 98 month | Unrealized Gain (Loss) on Derivatives 101 month | Unrealized Gain (Loss) on Derivatives 104 month | Unrealized Gain (Loss) on Derivatives 107 month | Unrealized Gain (Loss) on Derivatives 110 month | Unrealized Gain (Loss) on Derivatives 113 month | Unrealized Gain (Loss) on Derivatives 116 month | Unrealized Gain (Loss) on Derivatives 119 month | Unrealized Gain (Loss) on Derivatives 122 month | Unrealized Gain (Loss) on Derivatives 125 month | Unrealized Gain (Loss) on Derivatives 128 month | Unrealized Gain (Loss) on Derivatives 131 month |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2018-09-30 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2020-11-23 | $0.00 derived: sum of 2 quarters · filed 2020-11-23 | -$18.60K derived: sum of 3 quarters · filed 2020-11-23 | $432.14K 10-K · filed 2020-11-23 | ||||||||||||
| 2018-06-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2019-08-05 | -$18.60K derived: sum of 2 quarters · filed 2019-08-05 | $432.14K 10-Q · filed 2019-08-05 | -$197.01K derived: sum of 4 quarters · filed 2019-11-25 | ||||||||||||
| 2018-03-31 | -$18.60K 10-Q · filed 2019-05-08 | $432.14K 10-Q · filed 2019-05-08 | -$197.01K derived: sum of 3 quarters · filed 2019-11-25 | -$133.94K derived: sum of 4 quarters · filed 2019-11-25 | ||||||||||||
| 2017-12-31 | $450.74K 10-Q · filed 2019-02-07 | -$178.41K derived: sum of 2 quarters · filed 2019-11-25 | -$115.35K derived: sum of 3 quarters · filed 2019-11-25 | -$142.73K derived: sum of 4 quarters · filed 2019-11-25 | ||||||||||||
| 2017-09-30 | -$629.15K derived: 10-K 12 month − 10-Q 9 month · filed 2019-11-25 | -$566.09K derived: sum of 2 quarters · filed 2019-11-25 | -$593.47K derived: sum of 3 quarters · filed 2019-11-25 | $890.36K 10-K · filed 2019-11-25 | ||||||||||||
| 2017-06-30 | $63.06K 10-Q · filed 2018-08-07 | $35.68K derived: sum of 2 quarters · filed 2018-08-07 | $1.52M 10-Q · filed 2018-08-07 | $985.44K derived: sum of 4 quarters · filed 2018-12-11 | ||||||||||||
| 2017-03-31 | -$27.38K 10-Q · filed 2018-05-08 | $1.46M 10-Q · filed 2018-05-08 | $922.37K derived: sum of 3 quarters · filed 2018-12-11 | $809.01K derived: sum of 4 quarters · filed 2018-12-11 | ||||||||||||
| 2016-12-31 | $1.48M 10-Q · filed 2018-02-09 | $949.76K derived: sum of 2 quarters · filed 2018-12-11 | $836.40K derived: sum of 3 quarters · filed 2018-12-11 | $1.21M derived: sum of 4 quarters · filed 2018-12-11 | ||||||||||||
| 2016-09-30 | -$534.07K derived: 10-K 12 month − 10-Q 9 month · filed 2018-12-11 | -$647.43K derived: sum of 2 quarters · filed 2018-12-11 | -$277.50K derived: sum of 3 quarters · filed 2018-12-11 | -$301.02K 10-K · filed 2018-12-11 | ||||||||||||
| 2016-06-30 | -$113.36K 10-Q · filed 2017-08-03 | $256.58K derived: sum of 2 quarters · filed 2017-08-03 | $233.05K 10-Q · filed 2017-08-03 | $655.92K derived: sum of 4 quarters · filed 2017-12-12 | ||||||||||||
| 2016-03-31 | $369.94K 10-Q · filed 2017-05-03 | $346.41K 10-Q · filed 2017-05-03 | $769.27K derived: sum of 3 quarters · filed 2017-12-12 | $664.56K derived: sum of 4 quarters · filed 2017-12-12 | ||||||||||||
| 2015-12-31 | -$23.52K 10-Q · filed 2017-02-06 | $399.34K derived: sum of 2 quarters · filed 2017-12-12 | $294.63K derived: sum of 3 quarters · filed 2017-12-12 | $463.60K derived: sum of 4 quarters · filed 2017-12-12 | ||||||||||||
| 2015-09-30 | $422.86K derived: 10-K 12 month − 10-Q 9 month · filed 2017-12-12 | $318.15K derived: sum of 2 quarters · filed 2017-12-12 | $487.13K derived: sum of 3 quarters · filed 2017-12-12 | $2.87M 10-K · filed 2017-12-12 | ||||||||||||
| 2015-06-30 | -$104.71K 10-Q · filed 2016-08-09 | $64.26K derived: sum of 2 quarters · filed 2016-08-09 | $2.45M 10-Q · filed 2016-08-09 | $2.13M derived: sum of 4 quarters · filed 2016-12-14 | ||||||||||||
| 2015-03-31 | $168.97K 10-Q · filed 2016-05-10 | $2.55M 10-Q · filed 2016-05-10 | $2.23M derived: sum of 3 quarters · filed 2016-12-14 | $2.99M derived: sum of 4 quarters · filed 2016-12-14 | ||||||||||||
| 2014-12-31 | $2.38M 10-Q · filed 2016-02-09 | $2.06M derived: sum of 2 quarters · filed 2016-12-14 | $2.82M derived: sum of 3 quarters · filed 2016-12-14 | -$131.94K derived: sum of 4 quarters · filed 2016-12-14 | ||||||||||||
| 2014-09-30 | -$321.32K derived: 10-K 12 month − 10-Q 9 month · filed 2016-12-14 | $437.14K derived: sum of 2 quarters · filed 2016-12-14 | -$2.51M derived: sum of 3 quarters · filed 2016-12-14 | -$6.03M 10-K · filed 2016-12-14 | ||||||||||||
| 2014-06-30 | $758.47K 10-Q · filed 2015-08-04 | -$2.19M derived: sum of 2 quarters · filed 2015-08-04 | -$5.71M 10-Q · filed 2015-08-04 | -$11.23M derived: sum of 4 quarters · filed 2015-12-14 | ||||||||||||
| 2014-03-31 | -$2.95M 10-Q · filed 2015-05-11 | -$6.47M 10-Q · filed 2015-05-11 | -$11.99M derived: sum of 3 quarters · filed 2015-12-14 | -$11.79M derived: sum of 4 quarters · filed 2015-12-14 | -$8.49M 10-Q · filed 2014-05-06 | |||||||||||
| 2013-12-31 | -$3.52M 10-Q · filed 2015-02-09 | -$9.04M derived: sum of 2 quarters · filed 2015-12-14 | -$8.83M derived: sum of 3 quarters · filed 2015-12-14 | -$8.86M derived: sum of 4 quarters · filed 2015-12-14 | -$5.54M 10-Q · filed 2014-02-04 | |||||||||||
| 2013-09-30 | -$5.52M derived: 10-K 12 month − 10-Q 9 month · filed 2015-12-14 | -$5.32M derived: sum of 2 quarters · filed 2015-12-14 | -$5.34M derived: sum of 3 quarters · filed 2015-12-14 | -$5.30M 10-K · filed 2015-12-14 | -$2.02M 10-K · filed 2013-12-18 | |||||||||||
| 2013-06-30 | $200.75K 10-Q · filed 2014-08-12 | $171.34K derived: sum of 2 quarters · filed 2014-08-12 | $215.62K 10-Q · filed 2014-08-12 | $376.17K derived: sum of 4 quarters · filed 2014-11-25 | $3.50M 10-Q · filed 2013-08-07 | |||||||||||
| 2013-03-31 | -$29.40K 10-Q · filed 2014-05-06 | $14.87K 10-Q · filed 2014-05-06 | $175.43K derived: sum of 3 quarters · filed 2014-11-25 | $1.09M derived: sum of 4 quarters · filed 2014-11-25 | $3.30M 10-Q · filed 2013-05-09 | |||||||||||
| 2012-12-31 | $44.27K 10-Q · filed 2014-02-04 | $204.83K derived: sum of 2 quarters · filed 2014-11-25 | $1.12M derived: sum of 3 quarters · filed 2014-11-25 | $498.07K derived: sum of 4 quarters · filed 2014-11-25 | $3.33M 10-Q · filed 2013-02-13 | |||||||||||
| 2012-09-30 | $160.55K derived: 10-K 12 month − 10-Q 9 month · filed 2014-11-25 | $1.08M derived: sum of 2 quarters · filed 2014-11-25 | $453.80K derived: sum of 3 quarters · filed 2014-11-25 | $386.89K 10-K · filed 2014-11-25 | $3.28M 10-K · filed 2012-12-28 | |||||||||||
| 2012-06-30 | $915.39K 10-Q · filed 2013-08-07 | $293.24K derived: sum of 2 quarters · filed 2013-08-07 | $226.34K 10-Q · filed 2013-08-07 | $116.31K derived: sum of 4 quarters · filed 2013-08-07 | $3.12M 10-Q · filed 2012-08-13 | |||||||||||
| 2012-03-31 | -$622.14K 10-Q · filed 2013-05-09 | -$689.05K 10-Q · filed 2013-05-09 | -$799.08K derived: sum of 3 quarters · filed 2013-05-09 | -$425.34K derived: sum of 4 quarters · filed 2013-05-09 | $2.21M 10-Q · filed 2012-05-08 | |||||||||||
| 2011-12-31 | -$66.90K 10-Q · filed 2013-02-13 | -$176.93K derived: sum of 2 quarters · filed 2013-02-13 | $196.80K derived: sum of 3 quarters · filed 2013-02-13 | $600.95K derived: sum of 4 quarters · filed 2013-02-13 | $2.83M 10-Q · filed 2012-02-09 | |||||||||||
| 2011-09-30 | -$110.03K derived: 10-K 12 month − 10-Q 9 month · filed 2012-12-28 | $263.70K derived: sum of 2 quarters · filed 2012-12-28 | $667.86K derived: sum of 3 quarters · filed 2012-12-28 | $1.13M 10-K · filed 2012-12-28 | $2.89M 10-Q · filed 2012-08-13 | |||||||||||
| 2011-06-30 | $373.73K 10-Q · filed 2012-08-13 | $777.89K derived: sum of 2 quarters · filed 2012-08-13 | $1.24M 10-Q · filed 2012-08-13 | $1.45M derived: sum of 4 quarters · filed 2012-08-13 | $3.00M 10-Q · filed 2011-08-08 | |||||||||||
| 2011-03-31 | $404.15K 10-Q · filed 2012-05-08 | $869.42K 10-Q · filed 2012-05-08 | $1.08M derived: sum of 3 quarters · filed 2012-05-08 | $2.63M derived: sum of 4 quarters · filed 2012-05-08 | ||||||||||||
| 2010-12-31 | $465.27K 10-Q · filed 2012-02-09 | $674.43K derived: sum of 2 quarters · filed 2012-02-09 | $2.23M derived: sum of 3 quarters · filed 2012-02-09 | |||||||||||||
| 2010-09-30 | $209.16K derived: 10-K 12 month − 10-Q 9 month · filed 2011-12-20 | $1.76M derived: sum of 2 quarters · filed 2011-12-20 | $1.76M 10-K · filed 2011-12-20 | |||||||||||||
| 2010-06-30 | $1.55M 10-Q · filed 2011-08-08 | $1.55M 10-Q · filed 2011-08-08 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| CYTOKINETICS INC (CYTK) | United States | $9.130B | -11.86 |
| Protagonist Therapeutics, Inc (PTGX) | United States | $8.883B | 95.52 |
| TG THERAPEUTICS, INC. (TGTX) | United States | $8.805B | 19.05 |
| Axsome Therapeutics, Inc. (AXSM) | United States | $10.274B | -66.82 |
| Praxis Precision Medicines, Inc. (PRAX) | United States | $7.884B | -27.60 |
| Structure Therapeutics Inc. (GPCR) | United States | $7.710B | -53.41 |
| Spyre Therapeutics, Inc. (SYRE) | United States | $7.685B | -43.69 |
| Elanco Animal Health Inc (ELAN) | United States | $11.177B | -61.80 |
| IONIS PHARMACEUTICALS INC (IONS) | United States | $7.277B | -23.25 |
| Alkermes plc. (ALKS) | $6.844B | 132.74 |